Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

Abstract Aims Although heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause for hospitalization, its overall costs remain unclear. Therefore, we assessed the health care‐related costs of ambulatory HFpEF patients and the effect of spironolactone. Methods and results The ald...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Djawid Hashemi, Ludwig Dettmann, Tobias D. Trippel, Volker Holzendorf, Johannes Petutschnigg, Rolf Wachter, Gerd Hasenfuß, Burkert Pieske, Antonia Zapf, Frank Edelmann
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Oxford University Press 2020-06-01
Schriftenreihe:	ESC Heart Failure
Schlagworte:	Heart failure Heart failure with preserved ejection fraction Economic costs Economics
Online-Zugang:	https://doi.org/10.1002/ehf2.12606
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!